Inspire Medical Faces Investor Class Actions Over Inspire V Rollout

Overview

• In the District of Minnesota, a case titled City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., No. 25-cv-04247, seeks to represent buyers of Inspire stock from August 6, 2024 through August 4, 2025.
• The complaints allege the Inspire V launch faltered because many centers had not completed required training and onboarding, insurer claims software updates for billing did not take effect until July 1, and excess inventory dampened demand.
• Following the company’s August 4 disclosure of an elongated rollout and operational headwinds, Inspire cut 2025 EPS guidance by more than 80% to $0.40–$0.50, and the stock fell about $42.04 (roughly 32%), erasing around $1.2 billion in value.
• Robbins Geller, Robbins LLP, Kirby McInerney, Portnoy Law Firm, and Hagens Berman announced filings or investigations and are soliciting investors for the lead-plaintiff role.
• Most notices cite January 5, 2026 as the deadline to seek lead-plaintiff appointment under the PSLRA, though some firm announcements list January 5, 2025, creating a procedural discrepancy.